Sei Investments Co. boosted its holdings in shares of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Free Report) by 80.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 120,704 shares of the company’s stock after purchasing an additional 53,922 shares during the quarter. Sei Investments Co.’s holdings in Fresenius Medical Care AG & Co. KGaA were worth $2,723,000 at the end of the most recent quarter.
Other institutional investors also recently added to or reduced their stakes in the company. CIBC Private Wealth Group LLC lifted its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 398.2% during the third quarter. CIBC Private Wealth Group LLC now owns 1,380 shares of the company’s stock worth $36,000 after buying an additional 1,103 shares during the last quarter. Arax Advisory Partners grew its stake in shares of Fresenius Medical Care AG & Co. KGaA by 121.6% in the fourth quarter. Arax Advisory Partners now owns 1,613 shares of the company’s stock worth $38,000 after acquiring an additional 885 shares during the last quarter. Kestra Advisory Services LLC acquired a new stake in shares of Fresenius Medical Care AG & Co. KGaA in the fourth quarter worth $48,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in Fresenius Medical Care AG & Co. KGaA during the fourth quarter worth $58,000. Finally, Group One Trading LLC bought a new position in Fresenius Medical Care AG & Co. KGaA during the third quarter worth $74,000. 8.37% of the stock is owned by institutional investors.
Fresenius Medical Care AG & Co. KGaA Stock Performance
Shares of NYSE FMS opened at $24.27 on Friday. The firm has a market capitalization of $13.04 billion, a price-to-earnings ratio of 12.58, a PEG ratio of 4.29 and a beta of 0.77. Fresenius Medical Care AG & Co. KGaA has a one year low of $20.02 and a one year high of $27.64. The business has a fifty day simple moving average of $23.59 and a 200 day simple moving average of $23.02. The company has a current ratio of 1.07, a quick ratio of 0.86 and a debt-to-equity ratio of 0.43.
Wall Street Analysts Forecast Growth
A number of brokerages have weighed in on FMS. Weiss Ratings reissued a “hold (c)” rating on shares of Fresenius Medical Care AG & Co. KGaA in a report on Tuesday. Morgan Stanley restated an “underweight” rating on shares of Fresenius Medical Care AG & Co. KGaA in a report on Wednesday, May 6th. Wall Street Zen lowered shares of Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. Zacks Research upgraded shares of Fresenius Medical Care AG & Co. KGaA from a “strong sell” rating to a “hold” rating in a research note on Monday, July 6th. Finally, Sanford C. Bernstein increased their target price on shares of Fresenius Medical Care AG & Co. KGaA from $25.50 to $25.80 and gave the company a “market perform” rating in a research note on Thursday. Six analysts have rated the stock with a Hold rating and five have given a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Reduce” and an average target price of $23.57.
Get Our Latest Analysis on FMS
Fresenius Medical Care AG & Co. KGaA Company Profile
Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.
In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.
Featured Stories
- Five stocks we like better than Fresenius Medical Care AG & Co. KGaA
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Want to see what other hedge funds are holding FMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Free Report).
Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
